Fig. 2From: Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroidsGeometric mean ratio to baseline: a siVaw and b siRaw at Day 29. ****p ≤ 0.0001, **p < 0.01. Error bars show 95% CI. BGF budesonide/glycopyrrolate/formoterol fumarate, CI confidence interval, GFF glycopyrrolate/formoterol fumarate, siRaw specific image-based airway resistance, siVaw specific image-based airway volumeBack to article page